• Home
  • Event Information
  • Registration
  • Abstracts
  • Accomodation
  • Wells Center
  • IU Cancer Center
Abstracts Title Bar

The 10th Midwest Blood Club Symposium

You can download the detailed schedule here.

Thursday, March 15, 2012 – DAY 1

Indiana University, Riley Research, 699 Riley Hospital Drive, Indianapolis, IN 46202

11:00 - 12:00 PM Registration and Poster Set-Up
12:00 - 1:00 PM Lunch
1:00 - 1:15 PM Welcome
1:15 - 2:45 PM Oral Session I (5 Presentations) “Stem Cell Biology – HSC Cell Cycle and Self-Renewal” OPENING STATEMENT – “Role of Stem Cell Transplantation in the Treatment Of Hematologic Malignancies, Cancer, and Congenital Disorders”
2:45 - 3:00 PM Coffee Break
3:00 - 4:00 PM Linzhao Cheng, Ph.D. Professor of Stem Cell Program in the Institute of Cell Engineering Johns Hopkins Institute for Cell Engineering Johns Hopkins University School of Medicine Baltimore, MD
4:00 - 5:45 PM Oral Session II (6 Presentations) “Malignant Hematopoiesis – Signal Transduction” OPENING STATEMENT – “Limitations to Current Therapies for Leukemia and Lymphoma”
5:45 - 7:45 PM Poster Session and Reception
7:45 - 10:00 PM Dinner

Friday, March 16, 2012 – DAY 2

7:30 - 8:30 AM Breakfast
8:30 - 9:30 AM Oral Session III (3 presentations) “Myelodysplastic Syndrome and Myeloproliferative Disorders” OPENING STATEMENT – “Morbidity and Mortality Caused by MDS and MPD”
9:30 - 10:30 AM Keynote Speaker: John D. Crispino, Ph.D. Associate Professor of Medicine, Feinberg School of Medicine Associate Director of Education, Robert H Lurie Comprehensive Cancer Center Northwestern University
10:30 - 10:45 AM Coffee Break
10:45 - 12:15 PM Oral Session IV (6 Presentations) “Basic Science Bridging to Clinical Application” Dr. Hal Broxmeyer, Ph.D. and Dr. Sherif Farag, M.D. “Inhibition of CD26 for Enhanced Cord Blood Engraftment in Adults”
12:15 - 1:15 PM Lunch
1:15 - 2:45 PM Oral Session V (6 Presentations) “Gene Therapy and Stem Cell Biology – Mobilization, Circulation, and Migration” CLOSING STATEMENT – “Potential Applications of Gene Therapy for the Treatment of Human Disease”
2:45 - 3:00 PM Closing Remarks and Adjournment